Overview

Aom0319 SAD/MAD Study in Healthy Subjects

Status:
Not yet recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
This study consists of two parts, Parts A and B. Part A includes a single ascending dose(SAD) study and a multiple ascending dose(MAD) study in healthy Caucasian subjects. Part B includes a single ascending dose(SAD) study and a multiple ascending dose(MAD) study in healthy Chinese subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Amckaus PTY LTD.